Decreased hepatic ceramide levels by whole animal or tissue-specific ablation of dihydroceramide desaturase 1 in the liver or adipose tissue ameliorates hepatic steatosis and insulin resistance caused by obesogenic diets51. The gene discussed is DEGS1; the disease is fatty liver disease.